210 related articles for article (PubMed ID: 22904336)
1. Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001.
Lederman ER; Davidson W; Groff HL; Smith SK; Warkentien T; Li Y; Wilkins KA; Karem KL; Akondy RS; Ahmed R; Frace M; Shieh WJ; Zaki S; Hruby DE; Painter WP; Bergman KL; Cohen JI; Damon IK
J Infect Dis; 2012 Nov; 206(9):1372-85. PubMed ID: 22904336
[TBL] [Abstract][Full Text] [Related]
2. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
3. Preemptive Tecovirimat Use in an Active Duty Service Member Who Presented With Acute Myeloid Leukemia After Smallpox Vaccination.
Lindholm DA; Fisher RD; Montgomery JR; Davidson W; Yu PA; Yu YC; Burgado J; Wilkins K; Petersen BW; Okulicz JF
Clin Infect Dis; 2019 Nov; 69(12):2205-2207. PubMed ID: 30959520
[TBL] [Abstract][Full Text] [Related]
4. Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses.
Quenelle DC; Prichard MN; Keith KA; Hruby DE; Jordan R; Painter GR; Robertson A; Kern ER
Antimicrob Agents Chemother; 2007 Nov; 51(11):4118-24. PubMed ID: 17724153
[TBL] [Abstract][Full Text] [Related]
5. A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge.
Parker S; D'Angelo J; Buller RM; Smee DF; Lantto J; Nielsen H; Jensen A; Prichard M; George SL
Antiviral Res; 2021 Nov; 195():105179. PubMed ID: 34530009
[TBL] [Abstract][Full Text] [Related]
6. Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus.
Zaitseva M; McCullough KT; Cruz S; Thomas A; Diaz CG; Keilholz L; Grossi IM; Trost LC; Golding H
J Virol; 2015 Mar; 89(6):3295-307. PubMed ID: 25589648
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans.
Rice AD; Adams MM; Lampert B; Foster S; Robertson A; Painter G; Moyer RW
Viruses; 2011 Feb; 3(2):63-82. PubMed ID: 21369346
[TBL] [Abstract][Full Text] [Related]
8. Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice.
Berhanu A; King DS; Mosier S; Jordan R; Jones KF; Hruby DE; Grosenbach DW
Vaccine; 2010 Dec; 29(2):289-303. PubMed ID: 21036130
[TBL] [Abstract][Full Text] [Related]
9. Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin.
Fisher RW; Reed JL; Snoy PJ; Mikolajczyk MG; Bray M; Scott DE; Kennedy MC
Clin Vaccine Immunol; 2011 Jan; 18(1):67-74. PubMed ID: 21106779
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.
Grossi IM; Foster SA; Gainey MR; Krile RT; Dunn JA; Brundage T; Khouri JM
Antiviral Res; 2017 Jul; 143():278-286. PubMed ID: 28392420
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.
Parker S; Crump R; Foster S; Hartzler H; Hembrador E; Lanier ER; Painter G; Schriewer J; Trost LC; Buller RM
Antiviral Res; 2014 Nov; 111():42-52. PubMed ID: 25128688
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice.
Smee DF; Dagley A; Downs B; Hagloch J; Tarbet EB
Antimicrob Agents Chemother; 2015 Jan; 59(1):520-6. PubMed ID: 25385098
[TBL] [Abstract][Full Text] [Related]
13. Public health. Treating vaccine reactions: two lifelines, but no guarantees.
Enserink M
Science; 2002 Dec; 298(5602):2313. PubMed ID: 12493890
[No Abstract] [Full Text] [Related]
14. Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.
Grosenbach DW; Jordan R; King DS; Berhanu A; Warren TK; Kirkwood-Watts DL; Tyavanagimatt S; Tan Y; Wilson RL; Jones KF; Hruby DE
Vaccine; 2008 Feb; 26(7):933-46. PubMed ID: 18226434
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans.
Rice AD; Adams MM; Wallace G; Burrage AM; Lindsey SF; Smith AJ; Swetnam D; Manning BR; Gray SA; Lampert B; Foster S; Lanier R; Robertson A; Painter G; Moyer RW
Viruses; 2011 Jan; 3(1):47-62. PubMed ID: 21373379
[TBL] [Abstract][Full Text] [Related]
16. Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox.
Wei H; Huang D; Fortman J; Wang R; Shao L; Chen ZW
J Virol; 2009 Jan; 83(2):1115-25. PubMed ID: 19004937
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox.
Parker S; Chen NG; Foster S; Hartzler H; Hembrador E; Hruby D; Jordan R; Lanier R; Painter G; Painter W; Sagartz JE; Schriewer J; Mark Buller R
Antiviral Res; 2012 Apr; 94(1):44-53. PubMed ID: 22381921
[TBL] [Abstract][Full Text] [Related]
18. Severe eczema vaccinatum in a household contact of a smallpox vaccinee.
Vora S; Damon I; Fulginiti V; Weber SG; Kahana M; Stein SL; Gerber SI; Garcia-Houchins S; Lederman E; Hruby D; Collins L; Scott D; Thompson K; Barson JV; Regnery R; Hughes C; Daum RS; Li Y; Zhao H; Smith S; Braden Z; Karem K; Olson V; Davidson W; Trindade G; Bolken T; Jordan R; Tien D; Marcinak J
Clin Infect Dis; 2008 May; 46(10):1555-61. PubMed ID: 18419490
[TBL] [Abstract][Full Text] [Related]
19. Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models.
Achdout H; Lustig S; Israely T; Erez N; Politi B; Tamir H; Israeli O; Waner T; Melamed S; Paran N
Vaccine; 2017 Jul; 35(33):4245-4254. PubMed ID: 28625523
[TBL] [Abstract][Full Text] [Related]
20. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
Smee DF; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2001 Jan; 12(1):71-6. PubMed ID: 11437324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
